Navigation Links
onTargetjobs and ClearedConnections Announce Online Recruitment Partnership
Date:9/30/2008

Alliance will connect employers to candidates with active U.S. Security

Clearance

FORT WORTH, Texas, Sept. 30 /PRNewswire/ -- onTargetjobs and ClearedConnections announced today a new partnership that benefits those career candidates with an active U.S. Security Clearance who utilize the onTargetjobs network of niche career Web sites. The partnership includes cross-promotion and delivery of online job postings, advertising, and candidate resumes, as well as co-marketing and cooperation on relevant employment-related content.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/CLM027LOGO )

Through this unique alliance, ClearedConnections will extend their reach to a larger audience, with new career opportunities for intelligence jobs or federal government security clearance jobs now available to jobseekers for viewing on the onTargetjobs local career Web sites available under bizjournals.com/jobs.

"ClearedConnections' partnership with onTargetjobs allows us to expand our reach to new job seekers and employers across the U.S." said Robert Esti, Founder and Executive Director of ClearedConnections. "Our goal is to make certain that security cleared professionals have the resources they need to excel in the career path they choose."

"Through our partnership with ClearedConnections, onTargetjobs will better serve security cleared professionals and employers who seek to hire this specialized workforce," noted Mike Tansey, CEO of onTargetjobs. "We are always striving to expand our offering and value to job seekers and employers and this partnership provides that opportunity."

About onTargetjobs

onTargetjobs is the parent company of HEALTHeCAREERS.com, MedHunters.com, BioSpace.com, Hcareers.com, JobLoft.com, CareerBank.com, and RegionalHelpWanted.com providing online career services to the biotechnology, pharmaceutical, hospitality, restaurant, healthcare, accounting and finance, and geographically localized markets. onTargetjobs invests in leading niche Internet job sites, serving a defined geographic or vertical industry or job function. Partnership inquiries with onTargetjobs may be directed to Jeff Sauls, SVP Advertising & Ecommerce via email jeff.sauls@ontargetjobs.com or 817-717-1407.

About ClearedConnections

ClearedConnections founded in 1999, identifies individuals with an active Security Clearance and facilitates an introduction to corresponding hiring requirements. ClearedConnections, headquartered just outside Washington, DC in Reston, VA exclusively and securely connects U.S. Cleared Personnel with U.S. Cleared Facilities throughout the world. ClearedConnections is the first Internet career service dedicated to identifying individuals with an active Security Clearance and facilitates a safe introduction to authorized U.S. government contractors. The Company leverages the interactivity and sense of community possible on the Internet to build an effective secure service that generates a high level of customer loyalty and success. ClearedConnections web site is located at http://www.ClearedConnections.com.


'/>"/>
SOURCE onTargetjobs
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. onTargetjobs Announces Appointment of Michael Tansey as New CEO
2. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
3. Micromet Announces Definitive Agreement for $40 Million Private Equity Placement
4. Biotel Announces Record Revenues and Earnings for Fiscal 2008
5. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent
6. Helix BioPharma Announces $11.4 Million Private Placement
7. ULURU Inc. Announces the Filing of a 510k Submission With the FDA for Altrazeal(TM) Silver
8. Orexigen Therapeutics Announces Multiple Data Presentations at The Obesity Society Annual Scientific Meeting
9. Nomad Bioscience Announces Broad License Agreement
10. DSM and Crucell Announce Another Key Achievement for PER.C6(R) Technology; Scale Up of High-Titer Fed-Batch Process to 250 Liters
11. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Cambridge, MA (PRWEB) , ... January 20, 2017 ... ... and scientific consulting and resource to the healthcare industry ( http://www.gandlscientific.com ), has ... to its expanding team of clinical and scientific consultants and contractors. This is ...
(Date:1/21/2017)... , Jan. 20, 2017 Interpace ... a company that provides clinically useful molecular diagnostic ... has entered into a securities purchase agreement with ... 855,000 shares of common stock in a registered ... Company has agreed to sell to the same ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, today presented ... compound, napabucasin, at the 2017 American Society of Clinical ... Francisco . In a Phase ... agent designed to inhibit cancer stemness pathways by targeting ...
(Date:1/20/2017)... 20, 2017 Ginkgo Bioworks, the organism ... pioneer in the synthesis and assembly of DNA. ... assembling pathway-length synthetic DNA into Ginkgo,s automated organism ... the construction of new organism designs for application ... "Gen9 was founded to significantly increase the world,s ...
Breaking Biology Technology:
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/3/2017)... 3, 2017 Onitor, provider of digital health ... Track, an innovative biometric data-driven program designed to aid ... at the 2017 Consumer Electronics Show (CES) in ... the U.S., the World Health Organization (WHO), have identified ... adults who are overweight or obese. WHO also states ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
Breaking Biology News(10 mins):